Carcinogenesis, Teratogenesis & Mutagenesis ›› 2017, Vol. 29 ›› Issue (2): 139-142.doi: 10.3969/j.issn.1004-616x.2017.02.013

Previous Articles     Next Articles

Serum level and clinical diagnostic value of DKK1 in adenocarcinoma at the esophago-gastric junction

XU Yiwei1, GUO Hong2, GUO Haipeng3, PENG Yuhui1   

  1. 1. Department of Clinical Laboratory, Cancer Hospital of Shantou University Medical College, Shantou 515041;
    2. Department of Radiation Oncology, Cancer Hospital of Shantou University Medical College, Shantou 515041;
    3. Department of Head and Neck Surgery, Cancer Hospital of Shantou University Medical College, Shantou 515041, Guangdong, China
  • Received:2016-06-20 Revised:2017-01-15 Online:2017-03-31 Published:2017-03-31

Abstract:

OBJECTIVE: To study the serum level and diagnostic value of Dickkopf-1(DKK1) in patients with adenocarcinoma at the esophago-gastric junction (AEGJ). METHODS: Serum levels of DKK1 in 79 patients with AEGJ and 101 normal controls were measured by enzyme-linked immunosorbent assay (ELISA). Receiver operating characteristics (ROC) was used to calculate its diagnostic value. RESULTS: The serum levels of DKK1 were significantly higher in AEGJ than in normal controls (P=0.001). ROC curves showed that the optimum diagnostic cutoff for serum DKK1 was 2 615.9 pg/mL,providing an area under the curve (AUC) of 0.650 (95%CI:0.569-0.731),a sensitivity/specificity of 34.2%/95.0%. Moreover,serum DKK1 had early diagnostic value for AEGJ [AUC 0.674 (95%CI:0.521-0.827)],35.7% sensitivity and 96.0% specificity. Moreover,the positive rate of DKK1 was not significantly related to age,gender,size of tumor,depth of tumor invasion,lymph node status,or TNM stage (P > 0.05),but related to distant metastasis (P < 0.05). CONCLUSION: Serum levels of DKK1 was high in AEGJ patients which indicates that serum DKK1 may be a potential biomarker for early diagnosis of AEGJ.

Key words: DKK1, tumor marker, adenocarcinoma of esophago-gastric junction, diagnosis

CLC Number: